タカハシ　リナ   TAKAHASHI Rina   高橋　利奈    所属   医学部 医学科（東京女子医科大学病院）    職種   助教
言語種別	英語
発表タイトル	Role of a Patient-Centered Brochure in Reducing Anxiety and Supporting Participation in the Incremental Hemodialysis in Veterans (INCHVETS) Pragmatic Randomized Controlled Trial
会議名	Kidney Week 2025
主催者	American Society of Nephrology
学会区分	国際学会及び海外の学会
発表形式	ポスター掲示
講演区分	一般
発表者・共同発表者	◎Ismail Adnan M, Tran Diana, Simon Lewis, Takahashi Rina, Sy John, Siu Man Kit Michael, Tong Lili, Chang Yongen, Crowley Susan T, Unruh Mark L, Kovesdy Csaba P, Rhee Connie, Kalantar-Zadeh Kamyar,
発表年月日	2025/11/07
国名	アメリカ合衆国
開催地 （都市, 国名）	Houston, USA
開催期間	2025/11/05～2025/11/09
概要	Background Veterans initiating dialysis often face difficult decisions under stressful conditions. Introducing the concept of random dialysis frequency assignment versus choice of incremental transition (starting with twice weekly) and standard (outright thrice-weekly) hemodialysis (HD), can add further confusion and anxiety for patients, care-partners, and providers, deterring trial enrollment. To support recruitment and shared decision-making (SDM) in INCHVETS study, a Veteran-centered brochure was made and piloted. Methods Using excerpts from the informed consent document, we developed a Veteran-centered brochure to explain the INCHVETS trial’s rationale, procedures, and expectations. It had accessible language, culturally appropriate framing, and structured visuals, including Figure 1 to illustrate randomization. Emphasizing voluntary participation, the brochure addressed Veterans and their care-partners’ concerns and was piloted to screen and recruit eligible participants. Results Research staff at one site presented the brochure to 66 Veterans with CKD5, including those who recently initiated HD. Following brochure-assisted screening, 36 patients enrolled, mean age was 73.1±8.9 years; all were male, 30% Black, 30% Hispanic, and 64% had diabetes mellitus. During discussions, four patients or care-partners expressed concern about being randomized to thrice-weekly hemodialysis if twice-weekly were sufficient; one patient declined participation for this reason. In another case, a care-partner raised concerns about adequacy of twice-weekly therapy. Conclusion The INCHVETS brochure facilitates informed consent and reduces confusion around trial participation, particularly in relation to randomization versus patient-directed choice of dialysis frequency. By presenting complex study concepts in an accessible, Veteran-centered format, the brochure supported SDM and enrollment among a diverse incident dialysis population.